ArticleAnnals of medicine2026
Impact of national volume-based procurement on physicians' antimicrobial prescribing behaviours: an interrupted time series analysis of 1200 prescriptions in a tertiary hospital.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to investigate the impact of the National Volume-Based Procurement (NVBP) policy on antimicrobial use intensity, prescribing structure, and medical costs among inpatients in a tertiary hospital in China.
methodsThis study retrospectively extracted 1200 inpatient prescriptions from a tertiary hospital between April 2019 and March 2024. Using interrupted time series (ITS) analysis, the study assessed the immediate-level changes and long-term trend effects of the NVBP policy on medication indicators such as defined daily doses (DDDs) and costs.
resultsFollowing NVBP implementation, antimicrobial prescribing structure changed significantly, with β-lactam utilization decreasing by 13.85%. The combination rate of β-lactams + fluoroquinolones fell significantly by 75.93%, while overall combination therapy remained unchanged. Use of special-grade antimicrobials showed a numerical increase (+31.98%), although not statistically significant. Cost indicators decreased significantly following policy implementation. ITS analysis further revealed a significant immediate decrease in the proportion of DDDs for NVBP antimicrobial agents (
conclusionThis study demonstrates that while the NVBP policy significantly reduced patient drug expenditures and promoted the use of NVBP varieties and nonrestricted antimicrobial agents, it also increased the proportion of special-grade antimicrobials agents, suggesting the need for caution against potential antimicrobial resistance and strengthened supervision of prescription.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.